What if we told you that neither amiodarone nor lidocaine did any better in cardiac arrest when given by IO? What if we told you neither one improved survival when given by IV? Would you think I was smoking crack? Yeah, I would have thought that too until last week. I’m going to give a quick recap of this important secondary analysis of the ALPS trial, but only as a precursor to get y’all warmed up for the main event on Facebook Live Wednesday, January 29th at 8:30 CST. Listen to this podcast, and then join me, Mikey V, Eric Bauer, and Ritu Sahni as we talk about what we should make of this interesting trial. Most importantly, what we should do (or not do) in our clinical practice. As always, please subscribe and give us a 5-star rating on Apple Podcasts. We’d love to hear your thoughts, questions, and suggestions. Join us on Twitter: @MikeVerkest, @DrJeffJarvis, @EMSLighthouse @FlightBridgeED